These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2612 related articles for article (PubMed ID: 12829800)

  • 21. Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay.
    Perreard L; Fan C; Quackenbush JF; Mullins M; Gauthier NP; Nelson E; Mone M; Hansen H; Buys SS; Rasmussen K; Orrico AR; Dreher D; Walters R; Parker J; Hu Z; He X; Palazzo JP; Olopade OI; Szabo A; Perou CM; Bernard PS
    Breast Cancer Res; 2006; 8(2):R23. PubMed ID: 16626501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status.
    Flanagan JM; Cocciardi S; Waddell N; Johnstone CN; Marsh A; Henderson S; Simpson P; da Silva L; ; Khanna K; Lakhani S; Boshoff C; Chenevix-Trench G
    Am J Hum Genet; 2010 Mar; 86(3):420-33. PubMed ID: 20206335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
    Holm K; Staaf J; Lauss M; Aine M; Lindgren D; Bendahl PO; Vallon-Christersson J; Barkardottir RB; Höglund M; Borg Å; Jönsson G; Ringnér M
    Breast Cancer Res; 2016 Feb; 18(1):27. PubMed ID: 26923702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of tumor environmental response and oncogenic pathway activation identifies distinct basal and luminal features in HER2-related breast tumor subtypes.
    Gatza ML; Kung HN; Blackwell KL; Dewhirst MW; Marks JR; Chi JT
    Breast Cancer Res; 2011 Jun; 13(3):R62. PubMed ID: 21672245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eukaryotic translation initiation factor 4E (eIF4E) expression is associated with breast cancer tumor phenotype and predicts survival after anthracycline chemotherapy treatment.
    Heikkinen T; Korpela T; Fagerholm R; Khan S; Aittomäki K; Heikkilä P; Blomqvist C; Carpén O; Nevanlinna H
    Breast Cancer Res Treat; 2013 Aug; 141(1):79-88. PubMed ID: 23974830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes.
    Habibi G; Leung S; Law JH; Gelmon K; Masoudi H; Turbin D; Pollak M; Nielsen TO; Huntsman D; Dunn SE
    Breast Cancer Res; 2008; 10(5):R86. PubMed ID: 18925950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer.
    Cejalvo JM; Martínez de Dueñas E; Galván P; García-Recio S; Burgués Gasión O; Paré L; Antolín S; Martinello R; Blancas I; Adamo B; Guerrero-Zotano Á; Muñoz M; Nucíforo P; Vidal M; Pérez RM; Chacón López-Muniz JI; Caballero R; Peg V; Carrasco E; Rojo F; Perou CM; Cortés J; Adamo V; Albanell J; Gomis RR; Lluch A; Prat A
    Cancer Res; 2017 May; 77(9):2213-2221. PubMed ID: 28249905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors.
    Herschkowitz JI; Simin K; Weigman VJ; Mikaelian I; Usary J; Hu Z; Rasmussen KE; Jones LP; Assefnia S; Chandrasekharan S; Backlund MG; Yin Y; Khramtsov AI; Bastein R; Quackenbush J; Glazer RI; Brown PH; Green JE; Kopelovich L; Furth PA; Palazzo JP; Olopade OI; Bernard PS; Churchill GA; Van Dyke T; Perou CM
    Genome Biol; 2007; 8(5):R76. PubMed ID: 17493263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A gene expression signature that predicts the therapeutic response of the basal-like breast cancer to neoadjuvant chemotherapy.
    Lin Y; Lin S; Watson M; Trinkaus KM; Kuo S; Naughton MJ; Weilbaecher K; Fleming TP; Aft RL
    Breast Cancer Res Treat; 2010 Oct; 123(3):691-9. PubMed ID: 19967557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive profiling of biological processes reveals two major prognostic subtypes in breast cancer.
    Chen F; Gao S; Wang F; Ma J; Zhang M; Lv M; Zhou Q; Fu Z; Lu C; Yin H
    Tumour Biol; 2016 Mar; 37(3):3365-70. PubMed ID: 26446459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast cancer molecular subtypes respond differently to preoperative chemotherapy.
    Rouzier R; Perou CM; Symmans WF; Ibrahim N; Cristofanilli M; Anderson K; Hess KR; Stec J; Ayers M; Wagner P; Morandi P; Fan C; Rabiul I; Ross JS; Hortobagyi GN; Pusztai L
    Clin Cancer Res; 2005 Aug; 11(16):5678-85. PubMed ID: 16115903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of genes and pathways involved in breast cancer subtypes through gene expression meta-analysis.
    Jafarinejad-Farsangi S; Moazzam-Jazi M; Naderi Ghale-Noie Z; Askari N; Miri Karam Z; Mollazadeh S; Hadizadeh M
    Gene; 2022 May; 821():146328. PubMed ID: 35181505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA methylation epigenotypes in breast cancer molecular subtypes.
    Bediaga NG; Acha-Sagredo A; Guerra I; Viguri A; Albaina C; Ruiz Diaz I; Rezola R; Alberdi MJ; Dopazo J; Montaner D; Renobales M; Fernández AF; Field JK; Fraga MF; Liloglou T; de Pancorbo MM
    Breast Cancer Res; 2010; 12(5):R77. PubMed ID: 20920229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs.
    Riaz M; van Jaarsveld MT; Hollestelle A; Prager-van der Smissen WJ; Heine AA; Boersma AW; Liu J; Helmijr J; Ozturk B; Smid M; Wiemer EA; Foekens JA; Martens JW
    Breast Cancer Res; 2013 Apr; 15(2):R33. PubMed ID: 23601657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer.
    Bergamaschi A; Kim YH; Wang P; Sørlie T; Hernandez-Boussard T; Lonning PE; Tibshirani R; Børresen-Dale AL; Pollack JR
    Genes Chromosomes Cancer; 2006 Nov; 45(11):1033-40. PubMed ID: 16897746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subtypes of breast cancer show preferential site of relapse.
    Smid M; Wang Y; Zhang Y; Sieuwerts AM; Yu J; Klijn JG; Foekens JA; Martens JW
    Cancer Res; 2008 May; 68(9):3108-14. PubMed ID: 18451135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer.
    Bild AH; Parker JS; Gustafson AM; Acharya CR; Hoadley KA; Anders C; Marcom PK; Carey LA; Potti A; Nevins JR; Perou CM
    Breast Cancer Res; 2009; 11(4):R55. PubMed ID: 19638211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene expression profiling of breast cell lines identifies potential new basal markers.
    Charafe-Jauffret E; Ginestier C; Monville F; Finetti P; Adélaïde J; Cervera N; Fekairi S; Xerri L; Jacquemier J; Birnbaum D; Bertucci F
    Oncogene; 2006 Apr; 25(15):2273-84. PubMed ID: 16288205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A three-gene model to robustly identify breast cancer molecular subtypes.
    Haibe-Kains B; Desmedt C; Loi S; Culhane AC; Bontempi G; Quackenbush J; Sotiriou C
    J Natl Cancer Inst; 2012 Feb; 104(4):311-25. PubMed ID: 22262870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomas.
    Kuo WH; Chang YY; Lai LC; Tsai MH; Hsiao CK; Chang KJ; Chuang EY
    PLoS One; 2012; 7(9):e45831. PubMed ID: 23049873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 131.